CapyBio, a cell identity tools and services company, today announced the launch of three new commercial analysis services: Capybara™ Benchmarking Analysis, Capybara Advanced Analysis, and CellOracle™ ...
Increasingly complex cell therapy modalities, including multi-edit knock-in/knockout designs, are accelerating adoption of ...
UBC research associate Dr. Ross Jones in the lab where they are working to develop cell-based therapies from stem cells. Credit: Phillip Chin. For the first time, researchers at the University of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results